Atomwise vs Recursion

Side-by-side comparison of Atomwise and Recursion: pricing, features, API access, and community ratings.

AI comparison summary

Generating comparison…

	Atomwise AI superplatform that explores chemical space to discover novel, drug-like molecules Visit	Recursion Pioneering AI-driven drug discovery to decode biology and radically improve lives Visit
Category	Healthcare & biotech	Healthcare & biotech
Pricing	Enterprise	Enterprise
Starting price
Free tier
Audience	Technical	Technical
API available
Open source
Self-hostable
Model provider	Proprietary ML (AtomNet)	Proprietary (Recursion OS)
Founded	2012	2013
Headquarters	San Francisco, USA	Salt Lake City, USA
Key strengths	·AI-driven small-molecule drug discovery ·Exploration of vast chemical space beyond traditional screening ·Focus on first- and best-in-class immune/inflammatory disease programs ·Proprietary deep learning models for molecular binding prediction	·Massive proprietary biological dataset (>50 petabytes) spanning phenomics, transcriptomics, proteomics, and more ·Automated wet lab with robotics and computer vision generating millions of cell experiments per week ·Recursion OS — a continuously improving AI drug discovery and development platform ·BioHive-2 supercomputer built with NVIDIA for biopharma-scale compute